Impact of Physical Therapy Intervention on Foot and Ankle Function
1 other identifier
observational
80
1 country
1
Brief Summary
This research study will investigate the effect of physical therapy intervention on the function of the foot and ankle in children and adolescents with cancer not involving the brain or spinal cord. Children undergoing treatment for cancer can suffer from decreased flexibility, strength, balance and endurance from the cancer and from direct effects of the chemotherapy agents. These deficits have been shown to continue years after treatment end with adult survivors of cancer being less physically active then their siblings. Children, whose chemotherapy includes neurotoxic agents such as vincristine, can develop damage to their peripheral nervous system affecting the strength, sensation, and flexibility in their hands and feet. This can then lead to a change in their walking pattern and likely contributes to decreased physical activity level and fatigue. The principal investigator is currently involved in research with Dr. Laura Gilchrist and Dr. Mary C. Hooke establishing the reliability and validity of a measurement tool to quantify peripheral neuropathy, identifying physical impairments of children with cancer during treatment, and comparing physical performance in children after treatment completion with and without physical therapy intervention. The principal investigator is also completing data analysis on a pilot study investigating the use of ankle foot orthotics in children and adolescents with non-CNS cancer. In this study, the investigators will further the research by measuring the effect of physical therapy intervention on measurements involving the function and structure of the ankle and foot. The investigators will compare participants who have and have not received physical therapy intervention during cancer treatment by administering measurements detailing the function of the foot and ankle in order to further evaluate the benefit of physical therapy for children with cancer. Physical therapy intervention involving children and adolescents with cancer focuses on minimizing the physical impairments caused by chemotherapy and radiation treatment, as well as promoting normal development of motor skills typically obtained by a child in their age group. In the oncology population, physical therapy often targets the foot and ankle as this is most affected by peripheral neuropathy. Interventions include strengthening, balance training, stretching, and orthotic use to allow normal motor skills. Families are instructed in exercises that can be completed at home to further improve their function. This study will examine the difference in the function of the foot and ankle years after intervention in participants who have and have not received these interventions. The investigators will measure neuropathy, ankle flexibility, ankle strength, foot posture, gait mechanics, and endurance in order to fully examine the foot and ankle as well as evaluate relationships between the variables in long-term survivors of pediatric cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 18, 2012
CompletedFirst Submitted
Initial submission to the registry
April 27, 2021
CompletedFirst Posted
Study publicly available on registry
June 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 20, 2024
February 1, 2024
9 years
April 27, 2021
February 16, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Ankle range of motion
Active and passive ankle range of motion measured by goniometry
One day study
Ankle strength
Ankle plantarflexion and dorsiflexion dynamometry and manual muscle testing of ankle dorsiflexion and great toe extension
One day study
Secondary Outcomes (7)
Chemotherapy-induced peripheral neuropathy
One day study
Foot posture
One day study
Gait capacity
One day study
Gait
One day study
Running speed
One day study
- +2 more secondary outcomes
Study Arms (2)
Historical control group
Intervention group
Interventions
Had to receive 10 or more visits of physical therapy during the cancer treatment period to qualify for intervention group.
Eligibility Criteria
Diagnosed with a non-CNS cancer diagnosis with chemotherapy regimen including vincristine, carboplatin, or cisplatin greater than 5 years off of cancer treatment
You may qualify if:
- Historical control group
- Children and adolescents age 7-30
- English speaking family
- Diagnosed with a non-CNS cancer diagnosis with chemotherapy regimen including vincristine, carboplatin, or cisplatin
- Completed cancer treatment greater than 5 years ago
- Received less than 2 intervention visits of outpatient physical therapy during cancer treatment
- Intervention group
- Children and adolescents age 7-30
- English speaking family
- Completed cancer treatment greater than 5 years ago
- Greater than 10 physical therapy visits at Children's Hospitals and Clinics of MN
- Received PT evaluation within 6 months of starting cancer treatment.
You may not qualify if:
- Neurological impairments prior to cancer diagnosis
- Developmental disorders (Downs syndrome, chromosomal disorders)
- Non-English speaking parent/child
- Lower extremity or pelvic surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Minnesota
Minneapolis, Minnesota, 55404, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2021
First Posted
June 18, 2021
Study Start
December 18, 2012
Primary Completion
December 13, 2021
Study Completion
December 31, 2024
Last Updated
February 20, 2024
Record last verified: 2024-02